JANE STREET GROUP, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B902. A total of 4 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2023$1,187,340
+80.0%
33,000
+123.0%
0.00%–
Q4 2022$659,636
+40.6%
14,800
-11.4%
0.00%–
Q3 2022$469,000
-96.4%
16,700
-96.5%
0.00%
-100.0%
Q2 2022$12,925,000–479,400–0.01%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 31,300$1,690,0000.00%
SIMPLEX TRADING, LLC 1,300$44,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders